Association Between FDA Label Restriction and Immunotherapy and Chemotherapy Use in Bladder Cancer

This research letter discusses the association between label restrictions by the US Food and Drug Administration on first-line immunotherapy for advanced bladder cancer and subsequent changes in practice.

Na minha lista:
Detalhes bibliográficos
Publicado no:JAMA
Main Authors: Parikh, Ravi B., Adamson, Blythe J. S., Khozin, Sean, Galsky, Matthew D., Baxi, Shrujal S., Cohen, Aaron, Mamtani, Ronac
Formato: Artigo
Idioma:Inglês
Publicado em: American Medical Association 2019
Assuntos:
Research Letter
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6763996/
https://ncbi.nlm.nih.gov/pubmed/31550019
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jama.2019.10650
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados